The Home of the Life Sciences Industry

Explore Latest News

Aimmune Jumps On Phase III Peanut Allergy Trial Data

Aimmune Therapeutics announced late-stage trial results that showed its peanut allergy therapy was effective in more than 67 percent of juvenile patients.

FDA Gives AstraZeneca’s Imfinzi the Nod for New Lung Cancer Indication

The U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Imfinzi to treat patients with unresectable Stage III non-small cell lung cancer (NSCLC).


Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.